Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, previously known as Tianjin Zhong Xin Pharmaceutical Group, held its second extraordinary general meeting for FY2024. The meeting took place in Tianjin, China, with simultaneous video conferencing for international shareholders in Singapore. This gathering reflects the company’s commitment to engaging with its global shareholder base.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.